Amy Reed, a 40-year-old anesthesiologist from Boston, was the first woman to report “upstaged cancer” caused by a morcellation hysterectomy to the U.S. Food and Drug Administration(FDA) in October 2013. Since then, a number of women have filed reports with the FDA about morcellation and uterine cancer or filed morcellator cancer lawsuits against Johnson and Johnson (J&J) and other manufacturers.
Power morcellators are minimally invasive tools that mince the uterus and fibroids into small fragments and remove them through a tiny incision. The device can simultaneously blast cancerous cells into the abdomen and uterus and accelerate the spread of cancer.
Prior to her hysterectomy, Amy had undiagnosed Stage 1 leiomyosarcoma (LMS). The morcellation procedure increased Amy’s sarcoma to Stage 4 and decreased her lifespan. The life expectancy for Stage 4 LMS is only about two years.
A July 2014 study published in The Journal of the American Medical Association (JAMA) showed that one in 386 women undergoing a hysterectomy or myomectomy using morcellation has a risk of undiagnosed uterine cancer that could spread during morcellation. The study prompted Johnson & Johnson (J&J) to issue a worldwide withdraw of its Ethicon morcellators. J&J halted sales in April 2014 after the FDA discouraged the use of power morcellators due to the risk cancer spreading during the process.
Amy Reed has started a crusade to ban morcellators and posted a petition on change.org. She has over 14,000 signatures to date.

The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.